Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them.
Thermo Fisher Scientific
284 followers
Genentech
226 followers
Gilead Sciences
213 followers
Vertex Pharmaceuticals
111 followers
BioMarin Pharmaceutical
59 followers
Natera
33 followers
Cytiva
27 followers
Avantor
20 followers
SpringWorks Therapeutics
10 followers
Inari
7 followers
Precision For Medicine
3 followers
AbbVie
358 followers